Ozempic Shows Promise Treating Kidney Failure in Blow to Dialysis Firms
Novo Nordisk A/S diabetes drug Ozempic showed surprisingly early effectiveness in a kidney-failure study, sending shares of the world’s biggest dialysis providers tumbling. • None Hamas Got Around Israel’s Surveillance Prowess by Going Dark An independent data monitoring committee recommended…#novonordiskas #israel #novo #danish #frankfurt #davitainc #copenhagen #elilillyco #walmartinc #citigroupinc (Source: Reuters: Health)
Source: Reuters: Health - October 11, 2023 Category: Consumer Health News Source Type: news
Australia's Outback Dialysis Clinic Can Save Lives Australia's Outback Dialysis Clinic Can Save Lives
Three times a week, Rachel Napaltjarri, an Aboriginal woman suffering from end-stage kidney failure, receives lifesaving dialysis in a mobile medical unit.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 11, 2023 Category: Consumer Health News Tags: Nephrology News Source Type: news
Sask. woman can't access dialysis treatment close to home because clinic is just across Man. border
Maureen McBratney has to stay in Saskatoon, six hours away from home, because she needs dialysis treatment every other day and she's not allowed to be a regular patient at the dialysis unit 20 minutes from her home. (Source: CBC | Health)
Source: CBC | Health - October 11, 2023 Category: Consumer Health News Tags: News/Canada/Saskatoon Source Type: news
Dialysis company shares plunge after Ozempic trial success vs. kidney trouble
The trial success of Novo Nordisk’s hit drug against kidney failure sent shares of a German kidney dialysis services firm plummeting on Wednesday. Fresenius Medical Care shares FME, FMS, slumped 23%, and shares of its part owner Fresenius FRE, lost 12%, after Novo Nordisk halted a trial of…#novonordisks #freseniusmedicalcare #fme #fms #freseniusfre #novonordisk #nvs #copenhagen #danish #nestle (Source: Reuters: Health)
Source: Reuters: Health - October 11, 2023 Category: Consumer Health News Source Type: news
Tata Capital invests in dialysis chain based in Mumbai
The funding is done through Tata Capital Healthcare Fund II (TCHF II), the healthcare focused private equity fund of Tata Capital. About 90% of the funding will be for growth and 10% will provide exit to certain angel investors. Founded by nephrologists Jatin Kothari and Viswanath Billa, AKC has raised funds from founders and angel investors. (Source: The Economic Times)
Source: The Economic Times - October 10, 2023 Category: Consumer Health News Source Type: news
Are interventions for fatigue effective among people with kidney failure requiring dialysis?
Tuesday, October 10, 2023 (Source: Cochrane News and Events)
Source: Cochrane News and Events - October 10, 2023 Category: Information Technology Authors: Paolo Rosati Source Type: news
Enhancing triage and management in earthquake-related injuries: the SAFE-QUAKE scoring system for predicting dialysis requirements - Yilmaz S, Cetinkaya R, Ozel M, Tatliparmak AC, Ak R.
This study aimed to develop a predictive scoring system, named SAFE-QUAKE (Seismic Assessme... (Source: SafetyLit)
Source: SafetyLit - October 9, 2023 Category: International Medicine & Public Health Tags: Disaster Preparedness Source Type: news
FLOW, a Kidney Outcomes Trial of Semaglutide in T2D and CKD FLOW, a Kidney Outcomes Trial of Semaglutide in T2D and CKD
What have we learned from the FLOW trial about the effects of semaglutide among people with type 2 diabetes and chronic kidney disease?Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 6, 2023 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news
Similar Management Seen for Dialysis-Requiring AKI, ESKD Patients
THURSDAY, Oct. 5, 2023 -- Patients with dialysis-requiring acute kidney injury (AKI-D) are prescribed the same dialysis as end-stage kidney disease (ESKD) patients, but some AKI-D patients have the potential to recover, according to a research... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 5, 2023 Category: Pharmaceuticals Source Type: news
Bessemer, IFC looking to sell 30% stake in dialysis chain NephroPlus
The US-based Bessemer Venture Partners (BVP) and the World Bank's lending arm International Finance Corporation (IFC) are exploring the sale of about 30% stake in NephroPlus, said multiple people aware of the development. Bessemer and IFC will exit fully by selling about 30% stake together. However, the largest shareholder, Investcorp, is yet to decide on offloading its stake, added sources. Bahrain-based Investcorp owns about 40% stake in NephroPlus. (Source: The Economic Times)
Source: The Economic Times - October 3, 2023 Category: Consumer Health News Source Type: news
High Systemic Immune-Inflammation Index Tied to Higher Mortality With Peritoneal Dialysis
FRIDAY, Sept. 22, 2023 -- An elevated systemic immune-inflammation index (SII) is independently associated with increased risks for all-cause and cardiovascular-specific mortality in patients undergoing peritoneal dialysis, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 22, 2023 Category: Pharmaceuticals Source Type: news
Lessons Learned During the War in Ukraine Lessons Learned During the War in Ukraine
A new report from the Renal Disaster Relief Task Force sheds light on the consequences of war and disasters on the care and support of people with kidney disease.Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 22, 2023 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news
The Mount Sinai Hospital Commemorates 75th Anniversary of First Dialysis Procedure with Continuing Medical Education Event
The Dialysis Odyssey celebrates research advancements changing practice and improving lives of patients today NEW YORK, Sept. 21, 2023 /PRNewswire-PRWeb/ -- Seventy-five years after pioneering doctors at The Mount Sinai Hospital conducted the first hemodialysis treatment in the United... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 21, 2023 Category: Pharmaceuticals Tags: FVT Source Type: news
Stewart Cameron obituary
Leading British nephrologist who founded an internationally renowned kidney unit at Guy ’s hospital in LondonAs a bright young doctor at Guy ’s hospital in London in the 1960s, Stewart Cameron, who has died aged 89, was determined to be both clinician and researcher, but where should he focus his talents? Irreversible kidney failure – uniformly fatal until then – was just becoming treatable through dialysis or kidney transplantatio n; both were complex, demanding and dangerous, for patients and doctors alike.Stewart had found his metier and decided to make renal medicine his life ’s work. The first professor of r...
Source: Guardian Unlimited Science - September 19, 2023 Category: Science Authors: John Feehally Tags: Medical research Science Doctors Health Aberdeen Hospitals Source Type: news
eGFR With Creatinine and Kidney Transplant Outcomes eGFR With Creatinine and Kidney Transplant Outcomes
Estimated glomerular filtration rate based on serum creatinine may better determine the risk for adverse outcomes after kidney transplantation.Nephrology Dialysis Transplantation (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - September 15, 2023 Category: Transplant Surgery Tags: Nephrology Journal Article Source Type: news
